Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob A Miller

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Neuro-Oncology|February 24, 2019
The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasisRupesh Kotecha, Joseph M Kim, Jacob A Miller, et al.
Journal of Neurosurgery|August 12, 2017
Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcomeRupesh Kotecha, Jacob A Miller, Vyshak A Venur, et al.
Advances in Radiation Oncology|August 11, 2020
Continuing Medical Student Education During the Coronavirus Disease 2019 (COVID-19) Pandemic: Development of a Virtual Radiation Oncology ClerkshipErqi L Pollom, Navjot Sandhu, Jessica Frank, et al.
Neuro-Oncology|February 7, 2019
Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasisJoseph M Kim, Jacob A Miller, Rupesh Kotecha, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 10, 2025
Highly-multiplex detection of plasma cell-free human papillomavirus-16 DNA in oropharyngeal carcinomaPayton Clark, Natalya Karasik, Shauna R Campbell, et al.
Journal of Neurosurgery|January 20, 2019
Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastasesAditya Juloori, Jacob A Miller, Shireen Parsai, et al.
Head & Neck|August 3, 2022
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinomaJacob A Miller, Farshad Moradi, Vandana Sundaram, et al.
Journal of Neuro-Oncology|April 24, 2017
The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapiesJoseph M Kim, Jacob A Miller, Rupesh Kotecha, et al.
Journal of Clinical Microbiology|April 25, 2022
Evaluation of a Rapid and Accessible Reverse Transcription-Quantitative PCR Approach for SARS-CoV-2 Variant of Concern IdentificationPriscilla S-W Yeung, Hannah Wang, Mamdouh Sibai, et al.
Frontiers in Public Health|May 17, 2024
Polygenic risk-stratified screening for nasopharyngeal carcinoma in high-risk endemic areas of China: a cost-effectiveness studyDa-Wei Yang, Jacob A Miller, Wen-Qiong Xue, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Neuro-Oncology|February 24, 2019
The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasisRupesh Kotecha, Joseph M Kim, Jacob A Miller, et al.
Journal of Neurosurgery|August 12, 2017
Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcomeRupesh Kotecha, Jacob A Miller, Vyshak A Venur, et al.
Advances in Radiation Oncology|August 11, 2020
Continuing Medical Student Education During the Coronavirus Disease 2019 (COVID-19) Pandemic: Development of a Virtual Radiation Oncology ClerkshipErqi L Pollom, Navjot Sandhu, Jessica Frank, et al.
Neuro-Oncology|February 7, 2019
Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasisJoseph M Kim, Jacob A Miller, Rupesh Kotecha, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 10, 2025
Highly-multiplex detection of plasma cell-free human papillomavirus-16 DNA in oropharyngeal carcinomaPayton Clark, Natalya Karasik, Shauna R Campbell, et al.
Journal of Neurosurgery|January 20, 2019
Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastasesAditya Juloori, Jacob A Miller, Shireen Parsai, et al.
Head & Neck|August 3, 2022
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinomaJacob A Miller, Farshad Moradi, Vandana Sundaram, et al.
Journal of Neuro-Oncology|April 24, 2017
The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapiesJoseph M Kim, Jacob A Miller, Rupesh Kotecha, et al.
Journal of Clinical Microbiology|April 25, 2022
Evaluation of a Rapid and Accessible Reverse Transcription-Quantitative PCR Approach for SARS-CoV-2 Variant of Concern IdentificationPriscilla S-W Yeung, Hannah Wang, Mamdouh Sibai, et al.
Frontiers in Public Health|May 17, 2024
Polygenic risk-stratified screening for nasopharyngeal carcinoma in high-risk endemic areas of China: a cost-effectiveness studyDa-Wei Yang, Jacob A Miller, Wen-Qiong Xue, et al.
Pageof 11